Report Detail

Other Global Sanger’s Sequencing Service Market Size, Status and Forecast 2019-2025

  • RnM3199514
  • |
  • 21 May, 2020
  • |
  • Global
  • |
  • 97 Pages
  • |
  • QYResearch
  • |
  • Other

This report covers market size and forecasts of Sanger’s Sequencing Service, including the following market information:
Global Sanger’s Sequencing Service Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Sanger’s Sequencing Service Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Sanger’s Sequencing Service Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Sanger’s Sequencing Service Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

Key market players
Major competitors identified in this market include Source BioScience (UK), GenScript Biotech Corporation (US), Thermo Fisher Scientific, Inc. (US), LGC Science Group Limited (UK), Fasteris SA (Switzerland), CeMIA SA (Greece), Quintara Biosciences (US), GenHunter Corporation (US), GENEWIZ (US), Nucleics (Australia), SciGenom Labs Pvt. Limited (Inida), Microsynth AG. Inc. (Germany), etc.

Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)

Based on the Type:
Diagnostics
Biomarkers & Cancer
Reproductive Health
Personalized Medicine
Forensics
Others

Based on the Application:
Academic & Government Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Hospitals & Clinics


  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Sanger’s Sequencing Service Industry
  • 1.7 COVID-19 Impact: Sanger’s Sequencing Service Market Trends
  • 2 Global Sanger’s Sequencing Service Quarterly Market Size Analysis

    • 2.1 Sanger’s Sequencing Service Business Impact Assessment - COVID-19
      • 2.1.1 Global Sanger’s Sequencing Service Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Sanger’s Sequencing Service Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global Sanger’s Sequencing Service Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, Sanger’s Sequencing Service Headquarters and Area Served
    • 3.3 Date of Key Players Enter into Sanger’s Sequencing Service Market
    • 3.4 Key Players Sanger’s Sequencing Service Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Sanger’s Sequencing Service Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Diagnostics
      • 1.4.2 Biomarkers & Cancer
      • 1.4.3 Reproductive Health
      • 1.4.4 Personalized Medicine
      • 1.4.5 Forensics
      • 1.4.6 Others
    • 4.2 By Type, Global Sanger’s Sequencing Service Market Size, 2019-2021

    5 Impact of Covid-19 on Sanger’s Sequencing Service Segments, By Application

    • 5.1 Overview
      • 5.5.1 Academic & Government Research Institutes
      • 5.5.2 Pharmaceutical Companies
      • 5.5.3 Biotechnology Companies
      • 5.5.4 Hospitals & Clinics
    • 5.2 By Application, Global Sanger’s Sequencing Service Market Size, 2019-2021
      • 5.2.1 By Application, Global Sanger’s Sequencing Service Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Source BioScience (UK)
      • 7.1.1 Source BioScience (UK) Business Overview
      • 7.1.2 Source BioScience (UK) Sanger’s Sequencing Service Quarterly Revenue, 2020
      • 7.1.3 Source BioScience (UK) Sanger’s Sequencing Service Product Introduction
      • 7.1.4 Source BioScience (UK) Response to COVID-19 and Related Developments
    • 7.2 GenScript Biotech Corporation (US)
      • 7.2.1 GenScript Biotech Corporation (US) Business Overview
      • 7.2.2 GenScript Biotech Corporation (US) Sanger’s Sequencing Service Quarterly Revenue, 2020
      • 7.2.3 GenScript Biotech Corporation (US) Sanger’s Sequencing Service Product Introduction
      • 7.2.4 GenScript Biotech Corporation (US) Response to COVID-19 and Related Developments
    • 7.3 Thermo Fisher Scientific, Inc. (US)
      • 7.3.1 Thermo Fisher Scientific, Inc. (US) Business Overview
      • 7.3.2 Thermo Fisher Scientific, Inc. (US) Sanger’s Sequencing Service Quarterly Revenue, 2020
      • 7.3.3 Thermo Fisher Scientific, Inc. (US) Sanger’s Sequencing Service Product Introduction
      • 7.3.4 Thermo Fisher Scientific, Inc. (US) Response to COVID-19 and Related Developments
    • 7.4 LGC Science Group Limited (UK)
      • 7.4.1 LGC Science Group Limited (UK) Business Overview
      • 7.4.2 LGC Science Group Limited (UK) Sanger’s Sequencing Service Quarterly Revenue, 2020
      • 7.4.3 LGC Science Group Limited (UK) Sanger’s Sequencing Service Product Introduction
      • 7.4.4 LGC Science Group Limited (UK) Response to COVID-19 and Related Developments
    • 7.5 Fasteris SA (Switzerland)
      • 7.5.1 Fasteris SA (Switzerland) Business Overview
      • 7.5.2 Fasteris SA (Switzerland) Sanger’s Sequencing Service Quarterly Revenue, 2020
      • 7.5.3 Fasteris SA (Switzerland) Sanger’s Sequencing Service Product Introduction
      • 7.5.4 Fasteris SA (Switzerland) Response to COVID-19 and Related Developments
    • 7.6 CeMIA SA (Greece)
      • 7.6.1 CeMIA SA (Greece) Business Overview
      • 7.6.2 CeMIA SA (Greece) Sanger’s Sequencing Service Quarterly Revenue, 2020
      • 7.6.3 CeMIA SA (Greece) Sanger’s Sequencing Service Product Introduction
      • 7.6.4 CeMIA SA (Greece) Response to COVID-19 and Related Developments
    • 7.7 Quintara Biosciences (US)
      • 7.7.1 Quintara Biosciences (US) Business Overview
      • 7.7.2 Quintara Biosciences (US) Sanger’s Sequencing Service Quarterly Revenue, 2020
      • 7.7.3 Quintara Biosciences (US) Sanger’s Sequencing Service Product Introduction
      • 7.7.4 Quintara Biosciences (US) Response to COVID-19 and Related Developments
    • 7.8 GenHunter Corporation (US)
      • 7.8.1 GenHunter Corporation (US) Business Overview
      • 7.8.2 GenHunter Corporation (US) Sanger’s Sequencing Service Quarterly Revenue, 2020
      • 7.8.3 GenHunter Corporation (US) Sanger’s Sequencing Service Product Introduction
      • 7.8.4 GenHunter Corporation (US) Response to COVID-19 and Related Developments
    • 7.9 GENEWIZ (US)
      • 7.9.1 GENEWIZ (US) Business Overview
      • 7.9.2 GENEWIZ (US) Sanger’s Sequencing Service Quarterly Revenue, 2020
      • 7.9.3 GENEWIZ (US) Sanger’s Sequencing Service Product Introduction
      • 7.9.4 GENEWIZ (US) Response to COVID-19 and Related Developments
    • 7.10 Nucleics (Australia)
      • 7.10.1 Nucleics (Australia) Business Overview
      • 7.10.2 Nucleics (Australia) Sanger’s Sequencing Service Quarterly Revenue, 2020
      • 7.10.3 Nucleics (Australia) Sanger’s Sequencing Service Product Introduction
      • 7.10.4 Nucleics (Australia) Response to COVID-19 and Related Developments
    • 7.11 SciGenom Labs Pvt. Limited (Inida)
      • 7.11.1 SciGenom Labs Pvt. Limited (Inida) Business Overview
      • 7.11.2 SciGenom Labs Pvt. Limited (Inida) Sanger’s Sequencing Service Quarterly Revenue, 2020
      • 7.11.3 SciGenom Labs Pvt. Limited (Inida) Sanger’s Sequencing Service Product Introduction
      • 7.11.4 SciGenom Labs Pvt. Limited (Inida) Response to COVID-19 and Related Developments
    • 7.12 Microsynth AG. Inc. (Germany)
      • 7.12.1 Microsynth AG. Inc. (Germany) Business Overview
      • 7.12.2 Microsynth AG. Inc. (Germany) Sanger’s Sequencing Service Quarterly Revenue, 2020
      • 7.12.3 Microsynth AG. Inc. (Germany) Sanger’s Sequencing Service Product Introduction
      • 7.12.4 Microsynth AG. Inc. (Germany) Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      Summary:
      Get latest Market Research Reports on Sanger’s Sequencing Service . Industry analysis & Market Report on Sanger’s Sequencing Service is a syndicated market report, published as Global Sanger’s Sequencing Service Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Sanger’s Sequencing Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,250.00
      $4,875.00
      $6,500.00
      2,574.00
      3,861.00
      5,148.00
      3,009.50
      4,514.25
      6,019.00
      491,887.50
      737,831.25
      983,775.00
      271,050.00
      406,575.00
      542,100.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report